Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the long-term efficacy of acalabrutinib-based regimens in patients ...

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

Nicolas Martinez-Calle, MD, PhD, Nottingham University Hospitals NHS Trust, Nottingham, UK, provides insight into the rationale and results ...

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

Carsten Niemann, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, gives an overview of how Bruton's tyrosine kinase (BTK) ...

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

ALK+ large B-cell lymphoma (LBCL) is an aggressive lymphoma with dismal outcomes and with few treatment options.

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

Preetesh Jain, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into a Phase II trial ...

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

I pazienti affetti da leucemia linfatica cronica (Llc), la forma di leucemia più frequente, hanno da oggi a disposizione una nuova ...

Stream24-Il Sole 24 ORE